Sawgrass Asset Management LLC Pacira Bio Sciences, Inc. Transaction History

Sawgrass Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$54.64 - $61.3 $206,211 - $231,346	-3,774 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$59.18 - $69.99 $143,807 - $170,075	-2,430 Reduced 39.17%	3,774 $229,000
Q1 2021 Apr 29, 2021	SELL	$59.31 - $78.82 $71,468 - $94,978	-1,205 Reduced 16.26%	6,204 $435,000
Q4 2020 Jan 22, 2021	SELL	$50.47 - $66.26 $85,445 - $112,178	-1,693 Reduced 18.6%	7,409 $443,000
Q3 2020 Nov 02, 2020	BUY	$51.97 - $63.0 $42,875 - $51,975	825 Added 9.97%	9,102 $547,000
Q2 2020 Jul 27, 2020	BUY	$30.8 - $52.47 $254,931 - $434,294	8,277 New	8,277 $434,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.